Related Experiment Video
Updated: Apr 6, 2026

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
Published on: March 6, 2018
Conservative Treatment for Benign Prostatic Hyperplasia in Patients With Bladder Stones
Takashi Yoshida1, Hidefumi Kinoshita1, Takahiro Nakamoto1
1Department of Urology and Andrology, Kansai Medical University, Hirakata Hospital, Hirakata, Japan.
Insights
Conservative management of benign prostatic hyperplasia (BPH) is effective for men with bladder stones, showing significant symptom improvement and low complication rates. This approach offers a viable option for managing BPH alongside bladder stones.
Area of Science:
- Urology
- Medical Research
Background:
- Benign prostatic hyperplasia (BPH) and bladder stones often coexist.
- Conservative management strategies for BPH are well-established.
- The efficacy of conservative BPH management in patients with bladder stones requires further investigation.
Purpose of the Study:
- To evaluate the appropriateness of conservative management for BPH in patients diagnosed with bladder stones.
- To assess BPH-related complications following endoscopic bladder stone removal and subsequent conservative BPH treatment.
Main Methods:
- A cohort of 34 men with BPH and bladder stones underwent endoscopic bladder stone removal.
- Patients received conservative BPH management, including watchful waiting and medical therapy (alpha-blocker ± dutasteride).
- Outcomes measured included BPH-related complications, International Prostate Symptom Scores, quality of life, and postvoid residual urine volume.
Main Results:
- 76.5% of patients experienced no BPH-related complications over a mean follow-up of 52.6 months.
- International Prostate Symptom Scores significantly decreased post-treatment (P = .025).
- Complications included recurrent infections (2.9%), urinary retention (5.9%), and recurrent bladder stones (17.6%).
Conclusions:
- Conservative management of BPH is a suitable option for men with bladder stones and mild-to-moderate lower urinary tract symptoms.
- Prostate volume was identified as a significant preoperative predictor of complications.
- This approach demonstrates a favorable safety profile and symptom improvement.
Objective:
To determine whether conservative management of benign prostatic hyperplasia (BPH) is an appropriate option for patients with bladder stones.
Methods:
The study cohort comprised 34 men who underwent endoscopic bladder stone removal with subsequent conservative management of BPH, including watchful waiting and medical therapy (alpha-blocker ± dutasteride), between April 2006 and January 2014. We recorded BPH-related complications after stone removal and compared International Prostate Symptom Scores, quality of life scores, and postvoid residual urine volume before and after treatment. Cumulative BPH-related complication-free survival and the preoperative parameters associated with the occurrence of BPH-related complications were also analyzed.
Results:
Twenty-six patients (76.5%) treated with conservative management had no BPH-related complications, during a mean follow-up of 52.6 ± 30.9 months. Mean International Prostate Symptom Scores fell from 13.5 ± 7.1 before treatment to 9.7 ± 6.3 after treatment (P = .025). One of the 34 patients (2.9%) experienced recurrent urinary infections, 2 (5.9%) had urinary retention, and 6 (17.6%) developed recurrent bladder stones. The cumulative BPH-related complication-free survival was 97.0% at 1 year, 81.8% at 3 years, and 70.5% at 5 years. Six of the men (17.6%) underwent invasive intervention for BPH after occurrence of these complications. Prostate volume was the only preoperative parameter associated with the occurrence of complications after stone removal (P = .035).
Conclusion:
Conservative management of BPH can be an appropriate treatment option in men with bladder stones and concurrent mild-to-moderate lower urinary tract symptoms.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi V: Nursing Management
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi I: Introduction

